Association between hyperhomocysteinemia and primary pulmonary hypertension

Respiratory Medicine

Volumn 97, Issue 7, 2003, Pages 825-829

  Arroliga, Alejandro C ^a   Sandur, Sunder ^a   Jacobsen, Donald W ^a   Tewari, Sanjiv ^a   Mustafa, Masroor ^b   Mascha, Edward J ^a   Robinson, Killian ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperhomocysteinemia; Primary pulmonary hypertension

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DATA ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RISK ASSESSMENT; VITAMIN BLOOD LEVEL;

EID: 0038143332     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(03)00038-6     Document Type: Article

References (21)

1. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
2. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-7.
3. Nappo F, De Rosa N, Marfella R, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal be antioxidant vitamins. J Am Med Assoc 1999;281:2113-8.
4. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 1995;332:328-9.
5. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst[e]ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992;268: 877-81.
6. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
7. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
8. Zighetti ML, Cattaneo M, Falcon CR, et al. Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. Thromb Res 1997;85:279-82.
9. Upchurch Jr. GR, Welch GN, Fabian AJ, et al. Homocyst[e]ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-7.
10. Kanani PM, Sinkey CA, Browning RL, et al. Role of oxidant stress in endothelial function produced by experimental hyperhomocysto[e]inemia in humans. Circulation 1999;100:1161-8.
11. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after homocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
12. Kaneko FT, Arroliga AC, Dweik RA, et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 1998;158:917-23.
13. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994;40:873-81.
14. Refsum H, Ueland P, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
15. Gault MH, Longerich LL, Harnett JD, et al. Predicting glomerular functions from adjusted serum creatinine. Nephron 1992;62:249-56.
16. Van Guldener C, Robinson K. Homocysteine and renal disease. Semin Thomb Hemostasis 2000;26:313-24.
17. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxant factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
18. Blom HJ, Kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinemia. Eur J Clin Invest 1995;25:149-54.
19. Lentz SR. Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 1998;5:343-9.
20. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91: 6369-73.
21. Tsai JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocyst[e]ine in vascular smooth muscle cells. J Clin Invest 1996;97:146-53.